At the Bedside: CTLA-4- and PD-1-blocking antibodies in cancer immunotherapy

Clinical Review for Basic Researchers: Treating patients with CTLA‐4 and PD‐1 pathway blocking antibodies, plus clinical progress and application of agents in earlier stages of development. It is increasingly appreciated that cancers are recognized by the immune system, and under some circumstances,...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	Journal of leukocyte biology Ročník 94; číslo 1; s. 41 - 53
Hlavní autoři:	Callahan, Margaret K., Wolchok, Jedd D.
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	United States Society for Leukocyte Biology 01.07.2013
Témata:	Antibodies, Blocking - therapeutic use Clinical Trials as Topic CTLA-4 Antigen - antagonists & inhibitors CTLA-4 Antigen - immunology endpoints Humans Immunotherapy Neoplasms - immunology Neoplasms - therapy overall survival Paired Basic-Translational Reviews Programmed Cell Death 1 Receptor - antagonists & inhibitors Programmed Cell Death 1 Receptor - immunology tumor overall survival endpoints tumor
ISSN:	0741-5400, 1938-3673, 1938-3673
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!